Mobile

A Double-blind, Randomized, Placebo-controlled Multicentre Phase II Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases from Lung Cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-000889-36

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Main objective : To compare, in terms of time to progression (TTP) of the brain metastases, maintenance therapy with enzastaurin plus BSC vs. placebo plus BSC in patients with brain metastases from lung cancer who have completed whole brain radiotherapy (30 or 20 Gy)

Critère d'inclusion

  • brain metastastases of non-small or small cell lung cancer

Liens